BioSpace News Archive

Drug Development

UPDATED: In Major CRISPR Milestone, Intellia Successfully Edits Genes Inside the Body

Interim results from the Phase I study presented at the Peripheral Nerve Society Annual Meeting demonstrated that the investigational therapy, NTLA-2001, greatly reduced the disease-causing protein after a single infusion.

June 27, 2021
·
4 min read
·
Heather McKenzie
BioCapital

Dapagliflozin is Well Tolerated in Hospitalized COVID-19 Patients

DARE-19 is the first large randomized clinical trial to assess sodium-glucose cotransporter-2 inhibitors in patients with and without type 2 diabetes hospitalized with COVID-19.

June 27, 2021
·
5 min read
Biotech Bay

Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma

Innovent Biologics, Inc. announced that the National Medical Products Administration of China has approved the supplemental New Drug Application for TYVYT® in combination with BYVASDA® as a first-line treatment for people with advanced or unresectable hepatocellular carcinoma.

June 27, 2021
·
11 min read
Policy

Statement from the Chief Public Health Officer of Canada on June 27, 2021

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

June 27, 2021
·
5 min read